ALECTINIB HYDROCHLORIDE

ALECTINIB HYDROCHLORIDE was reported 7388 times

ALECTINIB HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPUR CELL ANAEMIA 7 0.1045
1 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 5 0.0758
2 NEOPLASM SWELLING 3 0.0556
3 INTRACRANIAL CALCIFICATION 2 0.0541
4 MALIGNANT NERVOUS SYSTEM NEOPLASM 2 0.0488
5 RED CELL FRAGMENTATION SYNDROME 2 0.0417
6 ANTIDIURETIC HORMONE ABNORMALITY 2 0.0238
7 TANNING 3 0.0204
8 PLEURODESIS 2 0.0198
9 RED BLOOD CELL MORPHOLOGY ABNORMAL 3 0.0196
10 PERICARDITIS MALIGNANT 2 0.0187
11 MALIGNANT NEOPLASM OLIGOPROGRESSION 3 0.0151
12 THORACIC CAVITY DRAINAGE 4 0.0150
13 HEART FAILURE WITH REDUCED EJECTION FRACTION 8 0.0150
14 PARALYSIS RECURRENT LARYNGEAL NERVE 2 0.0137
15 CENTRAL NERVOUS SYSTEM NEOPLASM 2 0.0124
16 CENTRAL NERVOUS SYSTEM NECROSIS 3 0.0109
17 ANAEMIA OF MALIGNANT DISEASE 3 0.0107
18 CHEST TUBE INSERTION 2 0.0106
19 NON-SMALL CELL LUNG CANCER RECURRENT 3 0.0106
20 METASTASES TO SPINAL CORD 2 0.0103
21 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 2 0.0103
22 HYDROTHORAX 8 0.0096
23 IRON BINDING CAPACITY TOTAL DECREASED 2 0.0090
24 RADIATION NECROSIS 5 0.0087
25 METASTASES TO THORAX 2 0.0079
26 INTRACRANIAL TUMOUR HAEMORRHAGE 3 0.0078
27 GASTROINTESTINAL LYMPHOMA 2 0.0077
28 DEFAECATION DISORDER 5 0.0075
29 SOLAR DERMATITIS 2 0.0074
30 POIKILOCYTOSIS 2 0.0072
31 METASTASES TO CENTRAL NERVOUS SYSTEM 92 0.0071
32 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 4 0.0065
33 BLOOD CREATINE PHOSPHOKINASE DECREASED 2 0.0061
34 MYOCARDIAL NECROSIS MARKER INCREASED 10 0.0060
35 PNEUMONIA ESCHERICHIA 2 0.0059
36 BRAIN NEOPLASM MALIGNANT 26 0.0058
37 PATERNAL EXPOSURE DURING PREGNANCY 5 0.0058
38 NON-SMALL CELL LUNG CANCER METASTATIC 5 0.0057
39 MUSCLE FATIGUE 24 0.0057
40 BLOOD BILIRUBIN UNCONJUGATED INCREASED 4 0.0055
41 NON-SMALL CELL LUNG CANCER STAGE IV 2 0.0055
42 IMPAIRED REASONING 2 0.0052
43 HAEMOLYTIC ANAEMIA 46 0.0051
44 CRANIOTOMY 2 0.0049
45 INTERCEPTED PRODUCT STORAGE ERROR 17 0.0048
46 GLIOSIS 2 0.0047
47 NON-SMALL CELL LUNG CANCER 22 0.0046
48 FIBROADENOMA OF BREAST 2 0.0044
49 BRAIN CANCER METASTATIC 3 0.0043
50 PHOTOSENSITIVITY REACTION 71 0.0043
51 INTRACRANIAL MASS 4 0.0042
52 OCULAR NEOPLASM 2 0.0042
53 INVESTIGATION ABNORMAL 6 0.0042
54 OVARIAN NEOPLASM 3 0.0039
55 RECURRENT CANCER 16 0.0039
56 BLOOD BILIRUBIN ABNORMAL 5 0.0039
57 ASPIRATION PLEURAL CAVITY 3 0.0039
58 CREATINE KINASE INCREASED 3 0.0039
59 BLOOD BILIRUBIN INCREASED 105 0.0039
60 RADIATION INJURY 4 0.0038
61 TUMOUR EXCISION 3 0.0037
62 RETICULOCYTE COUNT INCREASED 3 0.0037
63 BRAIN NEOPLASM 34 0.0037
64 PULMONARY TOXICITY 25 0.0035
65 METASTASES TO MENINGES 8 0.0035
66 LUNG CANCER METASTATIC 10 0.0035
67 PERIPHERAL NERVE INJURY 3 0.0034
68 DOSE CALCULATION ERROR 2 0.0034
69 HYPERBILIRUBINAEMIA 35 0.0034
70 COLON CANCER STAGE IV 2 0.0034
71 STEROID DIABETES 5 0.0033
72 LUNG ADENOCARCINOMA 10 0.0033
73 ONCOLOGIC COMPLICATION 3 0.0031
74 METASTASIS 21 0.0029
75 PLEURAL THICKENING 2 0.0029
76 BLOOD CREATINE PHOSPHOKINASE INCREASED 81 0.0028
77 BONE NEOPLASM 3 0.0028
78 METASTATIC NEOPLASM 12 0.0028
79 CHYLOTHORAX 2 0.0028
80 PNEUMONITIS 75 0.0028
81 CEREBRAL DISORDER 20 0.0027
82 SUNBURN 20 0.0027
83 READING DISORDER 6 0.0026
84 DYSCHEZIA 8 0.0026
85 NO ADVERSE EVENT 472 0.0026
86 HAEMOLYSIS 20 0.0026
87 BONE CANCER 11 0.0025
88 SKIN BACTERIAL INFECTION 2 0.0025
89 HAPTOGLOBIN DECREASED 2 0.0025
90 LIPIDS INCREASED 5 0.0025
91 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
92 LIP DISCOLOURATION 3 0.0024
93 MALIGNANT PLEURAL EFFUSION 4 0.0024
94 NEOPLASM RECURRENCE 8 0.0024
95 HEPATIC FUNCTION ABNORMAL 88 0.0024
96 CANCER PAIN 6 0.0023
97 RADIATION PNEUMONITIS 5 0.0023
98 OCULAR ICTERUS 10 0.0023
99 OEDEMA 125 0.0023
100 OESOPHAGEAL OBSTRUCTION 2 0.0023
101 SPINAL CORD NEOPLASM 2 0.0023
102 NEOPLASM 26 0.0023
103 BRAIN OPERATION 5 0.0022
104 METASTASES TO ADRENALS 2 0.0022
105 MICROANGIOPATHY 2 0.0021
106 LUNG NEOPLASM 9 0.0021
107 CONSTIPATION 455 0.0021
108 RED BLOOD CELL ABNORMALITY 2 0.0021
109 TASTE DISORDER 42 0.0021
110 TRAUMATIC LUNG INJURY 4 0.0021
111 LYMPHADENECTOMY 2 0.0020
112 LIVER FUNCTION TEST INCREASED 43 0.0020
113 PERICARDIAL EFFUSION 46 0.0020
114 HAEMANGIOMA OF LIVER 2 0.0020
115 CORONAVIRUS TEST POSITIVE 2 0.0019
116 INTERCEPTED MEDICATION ERROR 9 0.0019
117 LYMPHANGIOSIS CARCINOMATOSA 2 0.0019
118 METASTASES TO PLEURA 2 0.0019
119 LUNG OPACITY 5 0.0019
120 OPTIC NERVE DISORDER 3 0.0019
121 SKIN WRINKLING 5 0.0018
122 CLAUSTROPHOBIA 2 0.0018
123 DISEASE PROGRESSION 216 0.0018
124 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 6 0.0018
125 SARCOMA 2 0.0018
126 LOWER RESPIRATORY TRACT CONGESTION 3 0.0018
127 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
128 BLOOD CHLORIDE INCREASED 3 0.0017
129 BRADYCARDIA 92 0.0017
130 ERYTHEMA MULTIFORME 16 0.0017
131 VOCAL CORD PARALYSIS 3 0.0017
132 GASTROINTESTINAL OBSTRUCTION 4 0.0017
133 HAEMATOLOGICAL INFECTION 4 0.0016
134 PULMONARY ALVEOLAR HAEMORRHAGE 9 0.0016
135 ONYCHOCLASIS 11 0.0016
136 INTERSTITIAL LUNG DISEASE 77 0.0016
137 HEART RATE DECREASED 55 0.0016
138 BLOOD URIC ACID INCREASED 9 0.0016
139 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
140 FAECES HARD 6 0.0015
141 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
142 PULMONARY OEDEMA 68 0.0015
143 HERPES OPHTHALMIC 2 0.0015
144 HYPOVITAMINOSIS 2 0.0015
145 RENAL FUNCTION TEST ABNORMAL 7 0.0015
146 PLEURAL EFFUSION 91 0.0015
147 CARDIAC TAMPONADE 7 0.0015
148 SKIN DEPIGMENTATION 2 0.0015
149 ANAPHYLACTOID REACTION 6 0.0015
150 DEAFNESS UNILATERAL 8 0.0015
151 BLOOD CREATININE ABNORMAL 5 0.0014
152 HYPERTRANSAMINASAEMIA 10 0.0014
153 NEOPLASM PROGRESSION 50 0.0014
154 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
155 BLOOD ELECTROLYTES DECREASED 2 0.0014
156 METASTASES TO BONE 23 0.0014
157 TRANSAMINASES INCREASED 31 0.0014
158 APPENDICITIS 13 0.0014
159 FAT TISSUE INCREASED 2 0.0014
160 PULMONARY PAIN 4 0.0014
161 NORMOCYTIC ANAEMIA 2 0.0014
162 SINUS BRADYCARDIA 13 0.0013
163 PROTEIN TOTAL DECREASED 5 0.0013
164 DERMATITIS ACNEIFORM 8 0.0013
165 INFECTIOUS PLEURAL EFFUSION 2 0.0013
166 LUNG NEOPLASM MALIGNANT 54 0.0013
167 NEUROLOGICAL DECOMPENSATION 3 0.0013
168 DISCOURAGEMENT 3 0.0013
169 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
170 MYALGIA 212 0.0012
171 CYSTITIS INTERSTITIAL 2 0.0012
172 BREATH ODOUR 3 0.0012
173 BRADYPHRENIA 8 0.0012
174 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
175 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
176 GASTRIC DILATATION 2 0.0012
177 HYPERTRIGLYCERIDAEMIA 7 0.0012
178 METASTASES TO LIVER 21 0.0012
179 PRODUCT DISPENSING ERROR 26 0.0012
180 RED BLOOD CELL COUNT DECREASED 34 0.0012
181 METASTASES TO LYMPH NODES 8 0.0012
182 TROPONIN INCREASED 9 0.0012
183 APPENDICITIS PERFORATED 3 0.0012
184 LAZINESS 2 0.0012
185 PERIPHERAL SWELLING 180 0.0012
186 DRUG RESISTANCE 30 0.0012
187 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
188 PHYSICAL DECONDITIONING 3 0.0012
189 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
190 BRAIN FOG 18 0.0011
191 PARONYCHIA 5 0.0011
192 GASTROINTESTINAL STROMAL TUMOUR 3 0.0011
193 METASTASES TO LUNG 13 0.0011
194 FLUID RETENTION 57 0.0011
195 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
196 BONE LESION 4 0.0011
197 BRAIN OEDEMA 14 0.0011
198 ESSENTIAL HYPERTENSION 2 0.0011
199 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
200 BLOOD CREATININE INCREASED 70 0.0011
201 SMALL INTESTINAL PERFORATION 2 0.0011
202 NECK MASS 3 0.0011
203 BONE MARROW TRANSPLANT 2 0.0011
204 OESOPHAGEAL STENOSIS 3 0.0011
205 HYPOPROTEINAEMIA 2 0.0011
206 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
207 HYPERTONIC BLADDER 3 0.0010
208 LIVER DISORDER 46 0.0010
209 NEOPLASM MALIGNANT 69 0.0010
210 OEDEMA PERIPHERAL 126 0.0010
211 HEPATOTOXICITY 23 0.0010
212 HYPOGEUSIA 2 0.0010
213 HYPERCHLORHYDRIA 6 0.0010
214 GENE MUTATION 2 0.0010
215 THYROIDITIS 3 0.0010
216 CHOLANGITIS SCLEROSING 2 0.0010
217 VARICOSE VEIN 5 0.0010
218 CHEST INJURY 2 0.0010
219 SWELLING OF EYELID 6 0.0010
220 WEIGHT INCREASED 213 0.0010
221 FACE OEDEMA 16 0.0009
222 ANAEMIA MACROCYTIC 2 0.0009
223 COMPRESSION FRACTURE 5 0.0009
224 LANGUAGE DISORDER 2 0.0009
225 HEPATIC NEOPLASM 3 0.0009
226 PULMONARY THROMBOSIS 10 0.0009
227 CORONAVIRUS INFECTION 6 0.0009
228 MIDDLE EAR EFFUSION 2 0.0009
229 BLOOD CREATINE INCREASED 4 0.0009
230 DRUG ERUPTION 16 0.0009
231 FAECES PALE 2 0.0009
232 HEART RATE ABNORMAL 5 0.0009
233 ILEUS PARALYTIC 4 0.0009
234 METASTASES TO SPINE 3 0.0009
235 ADENOCARCINOMA 2 0.0009
236 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
237 NEUROLOGICAL SYMPTOM 5 0.0009
238 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
239 DENGUE FEVER 2 0.0009
240 MICTURITION DISORDER 3 0.0009
241 PATELLA FRACTURE 2 0.0009
242 YELLOW SKIN 4 0.0009
243 JAUNDICE CHOLESTATIC 3 0.0008
244 INTENTIONAL PRODUCT USE ISSUE 74 0.0008
245 DEATH 718 0.0008
246 HYPERCHOLESTEROLAEMIA 8 0.0008
247 SLOW SPEECH 2 0.0008
248 SWELLING 77 0.0008
249 BRONCHITIS CHRONIC 2 0.0008
250 GENERALISED OEDEMA 10 0.0008
251 HAEMATOCRIT DECREASED 16 0.0008
252 INFREQUENT BOWEL MOVEMENTS 2 0.0008
253 GASTROINTESTINAL TUBE INSERTION 2 0.0008
254 PLATELET DISORDER 2 0.0008
255 FRACTURE 15 0.0008
256 ASPARTATE AMINOTRANSFERASE INCREASED 42 0.0008
257 BRAIN ABSCESS 2 0.0008
258 HAEMOPTYSIS 22 0.0008
259 PRODUCT STORAGE ERROR 69 0.0008
260 COMMUNICATION DISORDER 3 0.0008
261 ABDOMINAL INFECTION 2 0.0008
262 NEURALGIA 19 0.0008
263 MYOSITIS 7 0.0008
264 MEAN CELL VOLUME INCREASED 2 0.0008
265 ATRIOVENTRICULAR BLOCK 6 0.0008
266 LUNG DISORDER 38 0.0008
267 DYSPHAGIA 73 0.0008
268 TONSILLITIS 4 0.0008
269 DEAFNESS 20 0.0008
270 VENOUS THROMBOSIS 3 0.0008
271 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
272 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
273 NEUROPATHY PERIPHERAL 71 0.0007
274 BLOOD SODIUM INCREASED 2 0.0007
275 HEPATIC ENZYME INCREASED 50 0.0007
276 HYPERURICAEMIA 3 0.0007
277 ILEUS 9 0.0007
278 GASTROINTESTINAL PERFORATION 3 0.0007
279 NECROSIS 4 0.0007
280 MASS 10 0.0007
281 PRODUCT PRESCRIBING ERROR 17 0.0007
282 LIMB DISCOMFORT 22 0.0007
283 HYPERPYREXIA 3 0.0007
284 ILL-DEFINED DISORDER 43 0.0007
285 PERIORBITAL SWELLING 4 0.0007
286 JAUNDICE 19 0.0007
287 HEPATIC CYTOLYSIS 9 0.0007
288 RESPIRATORY SYMPTOM 2 0.0007
289 PNEUMOTHORAX 11 0.0007
290 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
291 DIVERTICULITIS 19 0.0007
292 EOSINOPHILIA 12 0.0007
293 LUNG INFILTRATION 6 0.0007
294 FATIGUE 526 0.0007
295 IRON DEFICIENCY 3 0.0007
296 CEREBROVASCULAR DISORDER 2 0.0007
297 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
298 CRANIOCEREBRAL INJURY 2 0.0007
299 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
300 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
301 PIGMENTATION DISORDER 4 0.0006
302 CHOLANGITIS 4 0.0006
303 ROSACEA 3 0.0006
304 BLOOD BLISTER 2 0.0006
305 BLOOD CREATININE DECREASED 2 0.0006
306 LEUKAEMIA 6 0.0006
307 FOREIGN BODY IN THROAT 2 0.0006
308 HEPATOCELLULAR INJURY 9 0.0006
309 ANAEMIA 121 0.0006
310 HEPATITIS B REACTIVATION 2 0.0006
311 BILE DUCT STONE 2 0.0006
312 HEPATITIS 16 0.0006
313 TUMOUR MARKER INCREASED 3 0.0006
314 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
315 RASH VESICULAR 3 0.0006
316 RENAL IMPAIRMENT 52 0.0006
317 TENDON DISORDER 4 0.0006
318 JOINT SWELLING 74 0.0006
319 RASH 267 0.0006
320 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
321 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
322 EOSINOPHIL COUNT INCREASED 5 0.0006
323 COVID-19 105 0.0006
324 ERYSIPELAS 3 0.0006
325 MEMORY IMPAIRMENT 82 0.0006
326 DRUG TOLERANCE 3 0.0006
327 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
328 HEPATIC STEATOSIS 11 0.0006
329 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
330 HAEMOGLOBIN DECREASED 60 0.0006
331 LEFT VENTRICULAR FAILURE 2 0.0006
332 ENCEPHALITIS 4 0.0006
333 HAIR GROWTH ABNORMAL 4 0.0006
334 FAILURE TO THRIVE 3 0.0006
335 GRANULOMA 2 0.0006
336 LARGE INTESTINE PERFORATION 4 0.0006
337 THROMBOSIS 46 0.0006
338 NAIL DISORDER 5 0.0006
339 SKIN REACTION 8 0.0006
340 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
341 THERMAL BURN 4 0.0006
342 FIBRIN D DIMER INCREASED 2 0.0006
343 HAEMORRHAGIC DIATHESIS 2 0.0006
344 CARDIOTOXICITY 5 0.0006
345 MUSCULAR WEAKNESS 63 0.0006
346 HYPOKINESIA 8 0.0006
347 SPONDYLITIS 2 0.0005
348 BONE DISORDER 10 0.0005
349 BLOOD PHOSPHORUS DECREASED 2 0.0005
350 PRODUCT ADMINISTRATION ERROR 11 0.0005
351 SENSITIVE SKIN 4 0.0005
352 OFF LABEL USE 472 0.0005
353 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
354 LEUKOENCEPHALOPATHY 2 0.0005
355 INTESTINAL PERFORATION 6 0.0005
356 CHRONIC SINUSITIS 2 0.0005
357 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
358 ASTHENIA 200 0.0005
359 THERAPY INTERRUPTED 38 0.0005
360 HEPATIC NECROSIS 2 0.0005
361 PARANASAL SINUS HYPERSECRETION 2 0.0005
362 HAIR TEXTURE ABNORMAL 7 0.0005
363 HYPERSOMNIA 15 0.0005
364 SKIN DISCOLOURATION 24 0.0005
365 SKIN ATROPHY 3 0.0005
366 THYROID MASS 2 0.0005
367 GINGIVAL DISORDER 2 0.0005
368 APHTHOUS ULCER 4 0.0005
369 LUNG INFECTION 8 0.0005
370 SPINAL CORD COMPRESSION 2 0.0005
371 CARDIOPULMONARY FAILURE 2 0.0005
372 DYSGEUSIA 38 0.0005
373 PLEURISY 3 0.0005
374 CEREBRAL ATROPHY 2 0.0005
375 DEMENTIA 14 0.0005
376 UTERINE CANCER 4 0.0005
377 INTRACRANIAL ANEURYSM 2 0.0005
378 HEPATIC FAILURE 15 0.0005
379 SENSORY LOSS 4 0.0005
380 MUSCLE DISORDER 4 0.0005
381 DRY THROAT 5 0.0005
382 LIVER INJURY 12 0.0005
383 INITIAL INSOMNIA 5 0.0005
384 SPINAL STENOSIS 2 0.0005
385 MUSCLE INJURY 4 0.0005
386 EMBOLISM 4 0.0005
387 DRUG-INDUCED LIVER INJURY 15 0.0005
388 BONE PAIN 28 0.0005
389 BLOOD SODIUM DECREASED 9 0.0005
390 BLOOD CHOLESTEROL INCREASED 22 0.0005
391 INCREASED APPETITE 9 0.0005
392 PULMONARY MASS 7 0.0005
393 FACIAL PARALYSIS 4 0.0005
394 HEPATIC PAIN 2 0.0005
395 HIP FRACTURE 15 0.0005
396 BLOOD POTASSIUM DECREASED 14 0.0005
397 MYOPATHY 4 0.0005
398 HERPES SIMPLEX 3 0.0005
399 CHAPPED LIPS 2 0.0005
400 BIPOLAR DISORDER 5 0.0005
401 IMMOBILE 2 0.0005
402 OESOPHAGITIS 5 0.0005
403 DYSPHEMIA 2 0.0005
404 RHABDOMYOLYSIS 19 0.0005
405 DYSGRAPHIA 3 0.0005
406 COUGH 126 0.0004
407 MENINGITIS 3 0.0004
408 CARDIAC FAILURE 36 0.0004
409 NEPHROPATHY TOXIC 5 0.0004
410 PRODUCT USE COMPLAINT 7 0.0004
411 CHROMATURIA 10 0.0004
412 PAPILLOEDEMA 2 0.0004
413 SUSPECTED OFF LABEL USE 2 0.0004
414 PRODUCT LABEL ISSUE 3 0.0004
415 PNEUMONIA 143 0.0004
416 HYPOACUSIS 19 0.0004
417 ABDOMINAL DISTENSION 46 0.0004
418 EAR DISORDER 2 0.0004
419 LUMBAR VERTEBRAL FRACTURE 2 0.0004
420 PNEUMONIA BACTERIAL 4 0.0004
421 RESPIRATORY DISORDER 13 0.0004
422 LYMPHOEDEMA 3 0.0004
423 CHRONIC MYELOID LEUKAEMIA 2 0.0004
424 LOCALISED OEDEMA 2 0.0004
425 AUTOIMMUNE HEPATITIS 3 0.0004
426 ARTHRITIS INFECTIVE 2 0.0004
427 APHONIA 6 0.0004
428 MOUTH ULCERATION 9 0.0004
429 BLOOD TEST ABNORMAL 6 0.0004
430 TIBIA FRACTURE 2 0.0004
431 INTESTINAL OBSTRUCTION 16 0.0004
432 DYSPNOEA 240 0.0004
433 LYMPHADENOPATHY 15 0.0004
434 SPINAL DISORDER 4 0.0004
435 CHOLECYSTITIS 5 0.0004
436 VISUAL FIELD DEFECT 3 0.0004
437 ATELECTASIS 4 0.0004
438 GUILLAIN-BARRE SYNDROME 2 0.0004
439 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
440 THERAPY CESSATION 21 0.0004
441 CYTOPENIA 5 0.0004
442 ASCITES 12 0.0004
443 COGNITIVE DISORDER 19 0.0004
444 BREATH SOUNDS ABNORMAL 2 0.0004
445 HOSPICE CARE 4 0.0004
446 RASH MACULO-PAPULAR 9 0.0004
447 ORGANISING PNEUMONIA 2 0.0004
448 COLON CANCER 6 0.0004
449 HYDRONEPHROSIS 3 0.0004
450 SEIZURE 46 0.0004
451 RESPIRATORY FAILURE 29 0.0004
452 PAROSMIA 3 0.0004
453 DERMATITIS ALLERGIC 5 0.0004
454 DYSPHORIA 2 0.0004
455 MUSCLE ATROPHY 5 0.0004
456 PATHOLOGICAL FRACTURE 2 0.0004
457 DYSLIPIDAEMIA 2 0.0004
458 DRUG DISPENSING ERROR 6 0.0004
459 EPILEPSY 12 0.0004
460 PHLEBITIS 2 0.0004
461 MALIGNANT NEOPLASM PROGRESSION 40 0.0004
462 HYPOAESTHESIA 58 0.0004
463 AMNESIA 25 0.0004
464 APLASTIC ANAEMIA 2 0.0004
465 SPEECH DISORDER 20 0.0004
466 STOMATITIS 23 0.0004
467 SARS-COV-2 TEST POSITIVE 5 0.0004
468 INCONTINENCE 4 0.0004
469 RENAL CYST 3 0.0004
470 PRODUCTIVE COUGH 18 0.0004
471 BLOOD DISORDER 3 0.0004
472 GINGIVITIS 2 0.0004
473 HIP SURGERY 2 0.0004
474 HYPOXIA 13 0.0004
475 ASPHYXIA 3 0.0004
476 OSTEONECROSIS 12 0.0004
477 HYPERAESTHESIA 3 0.0004
478 PULMONARY FIBROSIS 7 0.0004
479 ASTHENOPIA 2 0.0004
480 SPINAL COMPRESSION FRACTURE 3 0.0004
481 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
482 INTRACRANIAL PRESSURE INCREASED 2 0.0004
483 DECREASED APPETITE 83 0.0004
484 PERICARDITIS 6 0.0004
485 OXYGEN SATURATION DECREASED 20 0.0004
486 EYE INFECTION 4 0.0004
487 SKIN TOXICITY 2 0.0004
488 CHOLECYSTITIS ACUTE 2 0.0004
489 PRODUCT CONTAINER ISSUE 3 0.0003
490 PARALYSIS 5 0.0003
491 GASTRIC HAEMORRHAGE 4 0.0003
492 CARDIAC MURMUR 3 0.0003
493 MOUTH SWELLING 2 0.0003
494 ENTEROCOLITIS 2 0.0003
495 HYPOTHYROIDISM 11 0.0003
496 ELECTROLYTE IMBALANCE 4 0.0003
497 RENAL DISORDER 16 0.0003
498 DYSPHONIA 20 0.0003
499 GRIP STRENGTH DECREASED 3 0.0003
500 BACK PAIN 79 0.0003
501 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
502 PURPURA 3 0.0003
503 ENERGY INCREASED 2 0.0003
504 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
505 PERITONITIS 7 0.0003
506 FACIAL PAIN 3 0.0003
507 PULMONARY HYPERTENSION 7 0.0003
508 HEAVY MENSTRUAL BLEEDING 3 0.0003
509 MYELOSUPPRESSION 12 0.0003
510 LIP SWELLING 11 0.0003
511 SKIN DISORDER 11 0.0003
512 BLOOD COUNT ABNORMAL 5 0.0003
513 EATING DISORDER 7 0.0003
514 RETINAL DETACHMENT 3 0.0003
515 PULMONARY EMBOLISM 31 0.0003
516 INCREASED TENDENCY TO BRUISE 3 0.0003
517 SKIN CANCER 7 0.0003
518 IRON DEFICIENCY ANAEMIA 3 0.0003
519 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
520 OLIGURIA 2 0.0003
521 THERAPY PARTIAL RESPONDER 5 0.0003
522 FLANK PAIN 3 0.0003
523 NASAL DRYNESS 2 0.0003
524 ARRHYTHMIA 15 0.0003
525 PHOTOPSIA 2 0.0003
526 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
527 OBESITY 5 0.0003
528 ACUTE RESPIRATORY FAILURE 6 0.0003
529 ALOPECIA 61 0.0003
530 NIGHT SWEATS 10 0.0003
531 HERNIA 6 0.0003
532 HIATUS HERNIA 4 0.0003
533 RENAL TUBULAR NECROSIS 3 0.0003
534 VITREOUS FLOATERS 3 0.0003
535 THERAPY CHANGE 3 0.0003
536 BEDRIDDEN 4 0.0003
537 PYREXIA 105 0.0003
538 APPETITE DISORDER 2 0.0003
539 SALIVARY HYPERSECRETION 3 0.0003
540 SKIN MASS 2 0.0003
541 BLOOD UREA INCREASED 5 0.0003
542 TOXIC SKIN ERUPTION 3 0.0003
543 ATRIAL FIBRILLATION 29 0.0003
544 EMPHYSEMA 3 0.0003
545 HEMIPARESIS 5 0.0003
546 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
547 ABNORMAL LOSS OF WEIGHT 2 0.0003
548 NEPHROTIC SYNDROME 2 0.0003
549 RIB FRACTURE 6 0.0003
550 HEPATIC CANCER 7 0.0003
551 GASTROINTESTINAL DISORDER 26 0.0003
552 MUSCLE SPASMS 53 0.0003
553 MENTAL IMPAIRMENT 7 0.0003
554 TENDERNESS 3 0.0003
555 POLLAKIURIA 12 0.0003
556 PETECHIAE 3 0.0003
557 HUNGER 4 0.0003
558 CEREBRAL INFARCTION 7 0.0003
559 DERMATITIS 6 0.0003
560 RENAL FAILURE 38 0.0003
561 CATARACT 17 0.0003
562 VISION BLURRED 39 0.0003
563 PANCREATITIS 15 0.0003
564 LYMPHOCYTE COUNT DECREASED 5 0.0003
565 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
566 ILLNESS 29 0.0003
567 MOVEMENT DISORDER 9 0.0003
568 DECREASED ACTIVITY 3 0.0003
569 PHARYNGITIS STREPTOCOCCAL 3 0.0003
570 ARTHRALGIA 115 0.0003
571 GASTRIC CANCER 7 0.0003
572 LIVER FUNCTION TEST ABNORMAL 8 0.0003
573 ORAL DISORDER 2 0.0003
574 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
575 BLOOD PRESSURE DECREASED 18 0.0003
576 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
577 RASH GENERALISED 7 0.0003
578 BLOOD CALCIUM DECREASED 3 0.0003
579 PAIN 163 0.0003
580 PEMPHIGOID 2 0.0003
581 APHASIA 8 0.0003
582 DIABETES MELLITUS 20 0.0003
583 GASTRIC DISORDER 9 0.0003
584 NEPHROLITHIASIS 12 0.0003
585 PROCEDURAL COMPLICATION 2 0.0003
586 PRODUCT DOSE OMISSION 17 0.0003
587 HOSPITALISATION 40 0.0003
588 MUSCLE TWITCHING 6 0.0003
589 DELIRIUM 9 0.0003
590 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
591 HYPOTENSION 52 0.0003
592 DRUG INTOLERANCE 25 0.0003
593 MUSCULOSKELETAL CHEST PAIN 4 0.0003
594 ANKLE FRACTURE 4 0.0003
595 VISUAL IMPAIRMENT 32 0.0003
596 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
597 DELUSION 4 0.0003
598 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
599 PELVIC FRACTURE 2 0.0003
600 MOOD ALTERED 7 0.0003
601 ACUTE MYELOID LEUKAEMIA 4 0.0003
602 NERVOUS SYSTEM DISORDER 8 0.0003
603 CHOKING 5 0.0003
604 ORAL HERPES 5 0.0003
605 SPLENOMEGALY 3 0.0003
606 SEXUAL DYSFUNCTION 3 0.0003
607 KIDNEY INFECTION 5 0.0003
608 DIZZINESS 127 0.0003
609 COVID-19 PNEUMONIA 3 0.0003
610 CEREBROVASCULAR ACCIDENT 43 0.0003
611 BLOOD ALBUMIN DECREASED 2 0.0003
612 PAIN IN EXTREMITY 74 0.0003
613 INFLUENZA 28 0.0003
614 HYPERLIPIDAEMIA 3 0.0003
615 ABSCESS 4 0.0003
616 ATRIAL FLUTTER 2 0.0003
617 PREGNANCY 5 0.0002
618 SPINAL FRACTURE 5 0.0002
619 THYROID CANCER 3 0.0002
620 HYPONATRAEMIA 14 0.0002
621 LOCALISED INFECTION 6 0.0002
622 MUSCLE TIGHTNESS 4 0.0002
623 BLOOD POTASSIUM INCREASED 4 0.0002
624 URINARY TRACT INFECTION 42 0.0002
625 DEEP VEIN THROMBOSIS 16 0.0002
626 SWELLING FACE 16 0.0002
627 BLINDNESS 10 0.0002
628 POLYURIA 2 0.0002
629 CHOLELITHIASIS 8 0.0002
630 SPINAL OPERATION 3 0.0002
631 LETHARGY 14 0.0002
632 MANIA 4 0.0002
633 ESCHERICHIA INFECTION 2 0.0002
634 OSTEOPOROSIS 10 0.0002
635 PARAESTHESIA 38 0.0002
636 MENSTRUAL DISORDER 2 0.0002
637 HEMIPLEGIA 2 0.0002
638 DRY SKIN 32 0.0002
639 GAIT INABILITY 8 0.0002
640 DYSPNOEA EXERTIONAL 9 0.0002
641 DIARRHOEA 154 0.0002
642 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
643 RENAL INJURY 7 0.0002
644 PSEUDOMONAS INFECTION 2 0.0002
645 INFLAMMATION 12 0.0002
646 LACRIMATION INCREASED 7 0.0002
647 PLATELET COUNT INCREASED 3 0.0002
648 FLATULENCE 13 0.0002
649 INTENTIONAL PRODUCT MISUSE 20 0.0002
650 GASTRITIS 6 0.0002
651 FEMUR FRACTURE 7 0.0002
652 EAR INFECTION 6 0.0002
653 MALIGNANT MELANOMA 3 0.0002
654 GASTROINTESTINAL INFECTION 2 0.0002
655 THERAPY NON-RESPONDER 10 0.0002
656 NASOPHARYNGITIS 41 0.0002
657 HEART RATE INCREASED 22 0.0002
658 OROPHARYNGEAL DISCOMFORT 2 0.0002
659 WHITE BLOOD CELL COUNT DECREASED 24 0.0002
660 PRURITUS 85 0.0002
661 OPTIC NEURITIS 2 0.0002
662 HYPERGLYCAEMIA 8 0.0002
663 PERIPHERAL COLDNESS 3 0.0002
664 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
665 NERVE COMPRESSION 2 0.0002
666 HYPOKALAEMIA 10 0.0002
667 RHINORRHOEA 14 0.0002
668 CHEST PAIN 40 0.0002
669 ORAL DISCOMFORT 3 0.0002
670 THINKING ABNORMAL 4 0.0002
671 INSOMNIA 57 0.0002
672 FALL 71 0.0002
673 ARTERIOSCLEROSIS 2 0.0002
674 SQUAMOUS CELL CARCINOMA 2 0.0002
675 SEASONAL ALLERGY 3 0.0002
676 PAIN IN JAW 6 0.0002
677 COLITIS 8 0.0002
678 NAUSEA 167 0.0002
679 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
680 PRODUCT PACKAGING ISSUE 2 0.0002
681 INTENTIONAL DOSE OMISSION 6 0.0002
682 CONFUSIONAL STATE 34 0.0002
683 DEHYDRATION 28 0.0002
684 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
685 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
686 PARAESTHESIA ORAL 3 0.0002
687 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
688 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
689 THROMBOTIC MICROANGIOPATHY 2 0.0002
690 SKIN FISSURES 4 0.0002
691 PHARYNGEAL SWELLING 2 0.0002
692 DISTURBANCE IN ATTENTION 11 0.0002
693 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
694 KNEE OPERATION 2 0.0002
695 PSYCHOTIC DISORDER 6 0.0002
696 RASH PRURITIC 11 0.0002
697 WHEEZING 12 0.0002
698 LIGAMENT SPRAIN 2 0.0002
699 DISORIENTATION 8 0.0002
700 SKIN EXFOLIATION 17 0.0002
701 UPPER LIMB FRACTURE 4 0.0002
702 PNEUMONIA ASPIRATION 5 0.0002
703 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
704 HAEMATEMESIS 5 0.0002
705 EYELID PTOSIS 2 0.0002
706 BALANCE DISORDER 17 0.0002
707 NEUTROPHIL COUNT DECREASED 8 0.0002
708 MOTOR DYSFUNCTION 2 0.0002
709 SLUGGISHNESS 2 0.0002
710 CEREBRAL HAEMORRHAGE 7 0.0002
711 NEUTROPHIL COUNT INCREASED 2 0.0002
712 DEVICE RELATED INFECTION 3 0.0002
713 EAR DISCOMFORT 2 0.0002
714 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
715 THYROID DISORDER 3 0.0002
716 SKELETAL INJURY 2 0.0002
717 POOR VENOUS ACCESS 2 0.0002
718 HAEMATOMA 5 0.0002
719 DIPLOPIA 5 0.0002
720 EYE DISCHARGE 2 0.0002
721 ACCIDENTAL OVERDOSE 7 0.0002
722 MUSCULOSKELETAL PAIN 10 0.0002
723 ABDOMINAL PAIN UPPER 39 0.0002
724 DEPRESSED MOOD 10 0.0002
725 FULL BLOOD COUNT ABNORMAL 2 0.0002
726 SOMNOLENCE 38 0.0002
727 RENAL PAIN 2 0.0002
728 ULCER 3 0.0002
729 SCIATICA 3 0.0002
730 SURGERY 11 0.0002
731 RETCHING 4 0.0002
732 BREAST PAIN 2 0.0002
733 HEADACHE 117 0.0002
734 INFECTION 27 0.0002
735 POOR QUALITY SLEEP 4 0.0002
736 BURNING SENSATION 13 0.0002
737 DRY MOUTH 15 0.0002
738 BACK DISORDER 3 0.0002
739 SEPTIC SHOCK 8 0.0002
740 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
741 DYSPEPSIA 18 0.0002
742 GAIT DISTURBANCE 35 0.0002
743 MUSCULOSKELETAL STIFFNESS 16 0.0002
744 EYE DISORDER 6 0.0002
745 RESPIRATORY DISTRESS 5 0.0002
746 ABNORMAL DREAMS 5 0.0002
747 DRY EYE 9 0.0002
748 MEDICATION ERROR 10 0.0002
749 NERVE INJURY 2 0.0002
750 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
751 URTICARIA 30 0.0002
752 NECK PAIN 10 0.0002
753 FISTULA 2 0.0002
754 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
755 HYPERSENSITIVITY 33 0.0002
756 HEART RATE IRREGULAR 4 0.0002
757 ACUTE KIDNEY INJURY 27 0.0002
758 IMPAIRED DRIVING ABILITY 2 0.0002
759 MYOCARDIAL ISCHAEMIA 2 0.0002
760 BRONCHITIS 13 0.0002
761 MALAISE 77 0.0002
762 BLOOD GLUCOSE INCREASED 33 0.0002
763 MICTURITION URGENCY 2 0.0002
764 EYELID OEDEMA 2 0.0002
765 WEIGHT DECREASED 48 0.0002
766 NASAL CONGESTION 10 0.0002
767 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
768 ACUTE MYOCARDIAL INFARCTION 5 0.0002
769 BLOOD IRON DECREASED 2 0.0002
770 VOMITING 79 0.0002
771 COMA 8 0.0002
772 RASH ERYTHEMATOUS 8 0.0002
773 ROAD TRAFFIC ACCIDENT 7 0.0002
774 GOUT 3 0.0002
775 POLYNEUROPATHY 2 0.0002
776 TOOTHACHE 3 0.0002
777 ARTHRITIS 13 0.0002
778 C-REACTIVE PROTEIN INCREASED 6 0.0002
779 NOCTURIA 2 0.0002
780 DYSURIA 6 0.0002
781 SMALL INTESTINAL OBSTRUCTION 2 0.0002
782 BLOOD GLUCOSE ABNORMAL 3 0.0002
783 HYPERCALCAEMIA 2 0.0002
784 CARDIAC FAILURE CONGESTIVE 13 0.0002
785 BACTERIAL INFECTION 3 0.0002
786 AGEUSIA 4 0.0002
787 SYNCOPE 16 0.0002
788 PLATELET COUNT DECREASED 17 0.0002
789 HYPOCALCAEMIA 3 0.0002
790 ANGIOEDEMA 7 0.0002
791 HEAD INJURY 5 0.0002
792 PRODUCT COMPLAINT 4 0.0002
793 PROTEINURIA 3 0.0002
794 HYPOPHAGIA 4 0.0002
795 CHEST DISCOMFORT 16 0.0002
796 LOWER LIMB FRACTURE 3 0.0002
797 THROAT IRRITATION 7 0.0002
798 ERECTILE DYSFUNCTION 4 0.0002
799 ERUCTATION 3 0.0002
800 ABDOMINAL DISCOMFORT 26 0.0002
801 EAR PAIN 3 0.0002
802 HAEMORRHOIDS 3 0.0002
803 SKIN IRRITATION 7 0.0002
804 MUCOSAL INFLAMMATION 4 0.0002
805 TINNITUS 7 0.0002
806 IMPAIRED HEALING 5 0.0002
807 INCORRECT PRODUCT STORAGE 2 0.0002
808 THROMBOCYTOPENIA 17 0.0002
809 PULMONARY CONGESTION 2 0.0002
810 BLOOD PRESSURE ABNORMAL 3 0.0002
811 VISUAL ACUITY REDUCED 5 0.0002
812 URINARY RETENTION 5 0.0001
813 CARDIAC DISORDER 14 0.0001
814 QUALITY OF LIFE DECREASED 2 0.0001
815 FEAR 4 0.0001
816 TYPE 2 DIABETES MELLITUS 5 0.0001
817 FEEDING DISORDER 3 0.0001
818 TACHYPNOEA 2 0.0001
819 EPISTAXIS 11 0.0001
820 BODY TEMPERATURE INCREASED 3 0.0001
821 IMPAIRED GASTRIC EMPTYING 2 0.0001
822 GINGIVAL BLEEDING 2 0.0001
823 SINUSITIS 15 0.0001
824 HALLUCINATION 11 0.0001
825 UNEVALUABLE EVENT 11 0.0001
826 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
827 TOOTH LOSS 3 0.0001
828 FEELING COLD 4 0.0001
829 HYPOMAGNESAEMIA 2 0.0001
830 SEPSIS 16 0.0001
831 COORDINATION ABNORMAL 2 0.0001
832 HYPERKALAEMIA 5 0.0001
833 BLINDNESS UNILATERAL 2 0.0001
834 ANGINA PECTORIS 4 0.0001
835 HERPES ZOSTER 8 0.0001
836 CELLULITIS 7 0.0001
837 MYELODYSPLASTIC SYNDROME 2 0.0001
838 PRODUCT PRESCRIBING ISSUE 3 0.0001
839 GASTROENTERITIS 2 0.0001
840 DYSSTASIA 4 0.0001
841 ERYTHEMA 28 0.0001
842 LABORATORY TEST ABNORMAL 4 0.0001
843 CARDIOMYOPATHY 2 0.0001
844 URINARY INCONTINENCE 4 0.0001
845 STEVENS-JOHNSON SYNDROME 3 0.0001
846 IMMUNODEFICIENCY 2 0.0001
847 ORAL PAIN 3 0.0001
848 ECZEMA 7 0.0001
849 ABDOMINAL PAIN 31 0.0001
850 HYPOAESTHESIA ORAL 2 0.0001
851 PRODUCT DOSE OMISSION ISSUE 39 0.0001
852 TREMOR 22 0.0001
853 DEPRESSION 30 0.0001
854 DRUG INEFFECTIVE 173 0.0001
855 VERTIGO 8 0.0001
856 DISCOMFORT 8 0.0001
857 INSURANCE ISSUE 2 0.0001
858 ANXIETY 37 0.0001
859 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
860 EMOTIONAL DISORDER 4 0.0001
861 OROPHARYNGEAL PAIN 12 0.0001
862 LYMPHOMA 2 0.0001
863 SLEEP DISORDER 9 0.0001
864 CYANOSIS 2 0.0001
865 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
866 MYOCARDIAL INFARCTION 22 0.0001
867 RESPIRATORY TRACT CONGESTION 2 0.0001
868 HALLUCINATION, AUDITORY 2 0.0001
869 EXTRA DOSE ADMINISTERED 5 0.0001
870 FIBROMYALGIA 3 0.0001
871 OSTEONECROSIS OF JAW 3 0.0001
872 COAGULOPATHY 2 0.0001
873 BLADDER CANCER 7 0.0001
874 ACNE 9 0.0001
875 CANDIDA INFECTION 2 0.0001
876 HYPERTENSION 25 0.0001
877 OSTEOARTHRITIS 5 0.0001
878 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
879 IRRITABILITY 7 0.0001
880 NIGHTMARE 4 0.0001
881 RESPIRATORY TRACT INFECTION 3 0.0001
882 ORTHOSTATIC HYPOTENSION 2 0.0001
883 NERVOUSNESS 6 0.0001
884 HAEMORRHAGE 12 0.0001
885 JOINT STIFFNESS 3 0.0001
886 NEUROTOXICITY 2 0.0001
887 AMENORRHOEA 2 0.0001
888 ISCHAEMIC STROKE 2 0.0001
889 GALLBLADDER DISORDER 2 0.0001
890 THIRST 2 0.0001
891 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
892 PALPITATIONS 13 0.0001
893 GASTROENTERITIS VIRAL 2 0.0001
894 OSTEOMYELITIS 2 0.0001
895 LIMB INJURY 3 0.0001
896 PANIC ATTACK 4 0.0001
897 TREATMENT NONCOMPLIANCE 6 0.0001
898 UNDERDOSE 8 0.0001
899 MENTAL STATUS CHANGES 3 0.0001
900 CONJUNCTIVITIS 2 0.0001
901 EYE SWELLING 4 0.0001
902 WOUND 3 0.0001
903 ASTHMA 12 0.0001
904 DISEASE RECURRENCE 5 0.0001
905 CHOLESTASIS 2 0.0001
906 PANCREATIC CARCINOMA 3 0.0001
907 CONTUSION 10 0.0001
908 GLAUCOMA 2 0.0001
909 LOSS OF CONSCIOUSNESS 13 0.0001
910 DISABILITY 2 0.0001
911 DRUG INTERACTION 16 0.0001
912 ADVERSE DRUG REACTION 9 0.0001
913 FEELING ABNORMAL 24 0.0001
914 PRODUCT PHYSICAL ISSUE 2 0.0001
915 BONE MARROW FAILURE 2 0.0001
916 FEELING HOT 6 0.0001
917 CARDIAC ARREST 8 0.0001
918 BREAST CANCER 9 0.0001
919 HALLUCINATION, VISUAL 2 0.0001
920 MIGRAINE 9 0.0001
921 CYSTITIS 3 0.0001
922 IMPAIRED WORK ABILITY 2 0.0001
923 RECTAL HAEMORRHAGE 4 0.0001
924 HOT FLUSH 7 0.0001
925 PRURITUS GENERALISED 2 0.0001
926 CHRONIC KIDNEY DISEASE 7 0.0001
927 MENTAL DISORDER 4 0.0001
928 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
929 STAPHYLOCOCCAL INFECTION 3 0.0001
930 VIRAL INFECTION 3 0.0001
931 COLITIS ULCERATIVE 4 0.0001
932 GLOSSODYNIA 2 0.0001
933 SNEEZING 2 0.0001
934 ANGER 3 0.0001
935 HAEMATURIA 3 0.0001
936 SHOCK 2 0.0001
937 RASH MACULAR 3 0.0001
938 HYPERHIDROSIS 11 0.0001
939 TREATMENT FAILURE 7 0.0001
940 THERAPEUTIC RESPONSE DECREASED 5 0.0001
941 LEUKOPENIA 4 0.0001
942 DRUG DOSE OMISSION 13 0.0001
943 CHILLS 9 0.0001
944 DRUG EFFECT DECREASED 4 0.0001
945 FREQUENT BOWEL MOVEMENTS 2 0.0001
946 BLISTER 4 0.0001
947 EYE PAIN 4 0.0001
948 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
949 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
950 INCORRECT DOSE ADMINISTERED 16 0.0001
951 MOBILITY DECREASED 5 0.0001
952 TACHYCARDIA 6 0.0001
953 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
954 CONDITION AGGRAVATED 20 0.0001
955 HYPOGLYCAEMIA 3 0.0001
956 INFLUENZA LIKE ILLNESS 5 0.0001
957 FEBRILE NEUTROPENIA 4 0.0001
958 FUNGAL INFECTION 2 0.0001
959 EYE PRURITUS 2 0.0001
960 NEUTROPENIA 8 0.0001
961 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
962 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
963 RESTLESSNESS 2 0.0001
964 HAEMATOCHEZIA 3 0.0001
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
966 PSORIASIS 7 0.0001
967 PLASMA CELL MYELOMA 2 0.0001
968 TOXICITY TO VARIOUS AGENTS 8 0.0000
969 BLOOD PRESSURE INCREASED 7 0.0000
970 PRODUCT QUALITY ISSUE 6 0.0000
971 ADVERSE EVENT 4 0.0000
972 INJURY 3 0.0000
973 SKIN BURNING SENSATION 3 0.0000
974 BLOOD GLUCOSE DECREASED 2 0.0000
975 FLUSHING 4 0.0000
976 ANAPHYLACTIC REACTION 2 0.0000
977 COMPLETED SUICIDE 3 0.0000
978 ARTHROPATHY 2 0.0000
979 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
980 PANCYTOPENIA 2 0.0000
981 RHEUMATOID ARTHRITIS 4 0.0000
982 EYE IRRITATION 2 0.0000
983 SUICIDE ATTEMPT 2 0.0000
984 PRODUCT USE ISSUE 5 0.0000
985 PROSTATE CANCER 2 0.0000
986 EMOTIONAL DISTRESS 3 0.0000
987 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
988 OVERDOSE 5 0.0000
989 SUICIDAL IDEATION 2 0.0000
990 INJECTION SITE PAIN 2 0.0000